$129.99
Stay ahead of critical regulatory changes with this in-depth course on the DEA’s proposed revisions to quota management for schedule I and II controlled substances, including ephedrine, pseudoephedrine, and phenylpropanolamine. Learn about new quota subcategories, revised application procedures, and the expanded role of stakeholder input in shaping the final regulation. Get practical knowledge to ensure compliance, prevent diversion, and understand the supply chain visibility requirements affecting manufacturers and importers.
In this course you will learn the following:
* Understand the goals and intent behind the proposed rule.
* Identify the key regulatory changes and their implications.
* Recognize the process for public participation and comment submission.
* Describe the structure and subcategories of manufacturing and procurement quotas.
* Assess the potential impact of the proposed rule on affected entities.
* Appreciate the evolving nature of the rule based on stakeholder input.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
Without this course, you risk being unprepared for significant regulatory changes that impact quota applications, supply chain transparency, and compliance with federal controlled substance regulations.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Revision of Applications for Manufacturing and Procurement Quotas.
Key regulatory references include:
Course SKU
FR-26-1934-1
CourseAvenue eLearning Platform has helped Federal agencies (and their suppliers) successfully address their most complex eLearning accessibility challenges.
Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment. Document Number: 2026-11526
Buy this Course
FR-26-1987-1
Why This Course is Important
Without this course, practitioners risk non-compliance with updated DEA rules, potential loss of prescribing privileges, audit failures, and exposure to significant legal and financial penalties.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment.
Key regulatory references include:
Course SKU
FR-26-1987-1
© 2026 CourseAvenue, LLC | All rights reserved.
